1[1]Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease. Am J Kidney Dis, 1998, 32(Suppl):112- 119.
2[2]Robert N, Patick S, Partfrey, et al. Impact of hypertension on cardiomyopathy, morbidity and mortality in end stage renal disease. Kidney Int, 1996, 49:1379 - 1385.
3[3]Robert N, Patick S, Partfrey, et al. The impact of anemia on cardiomyopathy, morbidity and mortality in end stage renal disease. Am J Kidney Dis, 1996, 28(1): 53-61.
4[4]Cressman MD, Heyka RJ, Paganini EP, et al. Lipoprotein (a) is an independent risk factor of cardiovascular disease in hemodialysis patients. Circulation, 1992, 86 (2): 475 -482.
5[5]Stack A, Bloemberrgen WE. Predictors and clinical correlates of CAD among incident US dialysis patients (abstracts). J Am Soc Nephrol, 1998, 9: 227.
6[6]Bloembergen WE, Port FK, Mauger EA. A comparison of cause of death between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol, 1995, 6:184 -191.
7[7]Bergstrom J, Lindholm B. Malnutrition, cardiac disease and mortality: an intergrated point of view. Am J Kidney Dis,1998, 32: 834-841.
